Acne: prepubertal

LAST UPDATED: Nov 21, 2021

Introduction

Prepubertal acne is relatively common, and is generally not associated with significant underlying endocrinopathy. 

This chapter is set out as follows:


Aetiology

  • There are usually no significant underlying endocrinopathies and, in the absence of precocious puberty or other developmental abnormalities, investigations are not needed

History

  • It is more common in boys and presents between the ages of three and 18 months, and may last up to the age of three years

Clinical findings

  • The severity is usually mild-moderate but occasionally can be severe
  • The face is the most frequently affected site, often with a mixture of comedones, papules and pustules
  • Nodules and scarring occasionally occur 

Clinical Images

Please refer to notes on image rights at bottom of the page with regards to individual image ownership.


Management

  • Refer to the acne section in the concise guidelines. Tetrayclines must be avoided in children aged under 12 years
  • On occasions acne can be severe with nodules or scarring, such patients should be referred urgently for consideration of treatment with isotretinoin 

Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.

Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.

Quick Links

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco